A federal health advisory panel has voted to recommend lifting restrictions on several peptides, which are popular among wellness influencers. This decision comes despite warnings from government scientists regarding the safety and efficacy of these substances, including BPC-157 and TB-500.
Watch for potential shifts in telehealth marketing strategies as the FDA may ease peptide restrictions. The outcome could influence wellness trends and regulatory debates, especially with figures like RFK Jr. advocating for broader access amid safety concerns.